In the latest trading session, Astera Labs, Inc. (ALAB) closed at $129.70, marking a -0.82% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 1.54% for the day.

Scientists have collected troves of DNA and microscopic imaging data from human cells—and now they have a tool that might ...

We warn that Astera Labs stock may be overvalued, and bearish technicals indicate a sell signal despite strong growth. See ...

We recently published a list of 15 AI Stocks That Skyrocketed in Q4. In this article, we are going to take a look at where ...

In this article, we are going to take a look at where Astera Labs, Inc. (NASDAQ:ALAB) stands against other stocks analysts are talking about. Marco Argenti, Chief Information Officer at Goldman ...

The year 2024 will likely be remembered as a turning point in the stock market, with leadership broadening well beyond the “Magnificent Seven” that dominated the previous year. In 2023, the stock ...

Morgan Stanley recently increased its price target on Astera Labs Inc (NASDAQ:ALAB) to $142 from $94. “[The] industry view remains attractive, as AI strength now dominates the index weightings ...

Investors with a lot of money to spend have taken a bullish stance on Astera Labs ALAB. And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Below is Validea's guru fundamental report for ASTERA LABS INC (ALAB). Of the 22 guru strategies we follow, ALAB rates highest using our P/B Growth Investor model based on the published strategy ...

Morgan Stanley analyst Joseph Moore maintained a Buy rating on Astera Labs, Inc. (ALAB – Research Report) today and set a price target of $142.00. The company’s shares opened today at $122.75.

From Morgan Stanley (NYSE:MS) on Friday, Broadcom (NASDAQ:AVGO), Astera Labs (NASDAQ:ALAB), and Marvell Technology (NASDAQ:MRVL) got price target bumps as the company evaluated their prospects for ...